REAL-WORLD DATA (RWD) / REAL-WORD EVIDENCE (RWE) INSIGHTS
-
![Partnership, merger, alliance, integration GettyImages-1019177936]( "Is Double Programming Really Required For Validation?")
Is Double Programming Really Required For Validation?Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.
-
![teamwork collaboration data analysis-GettyImages-1473508651]( "Meaningful Industry Change Means Balancing Tech And Human Touch")
Meaningful Industry Change Means Balancing Tech And Human TouchTechnology and AI/ML are advancing at an unprecedented pace, and we must not lose sight of our industry's core: human-to-human interaction.
RWD/RWE VIDEOS
Explore how clinical trial sponsors can benefit from the growing use of electronic source (eSource) technology at research sites.
Discover how TA Scan’s Trial Feasibility Flex transforms feasibility planning from reactive to proactive—accelerating timelines and reducing risk.
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
Discover a trial feasibility tool that integrates users' operational insights with high-quality clinical intelligence to drive accurate and informed enrollment projections and site capacity analyses.
RWD/RWE RESOURCES
-
![esource image]( "Why Research Sites Don't Use EMR As The Source Data Collection Tool")
Why Research Sites Don't Use EMR As The Source Data Collection ToolExamine the limitations of using Electronic Medical Records (EMRs) in clinical research compared to eSource systems.
-
![GettyImages-1314466105 breast cancer]( "6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies")
6 Key Ways Real-World Data Is Accelerating Breast Cancer TherapiesReal-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.
-
![GettyImages-1394446062 regulatory]( "2024 MedTech Regulatory Updates: 4 Areas Of Interest")
2024 MedTech Regulatory Updates: 4 Areas Of InterestIn 2024, McKinsey's projections foresee a promising year for the MedTech industry, driven by innovation but shadowed by regulatory uncertainty.
-
![GettyImages-1279248902 data links]( "Enhancing Clinical Trials By Linking Them To RWD")
Enhancing Clinical Trials By Linking Them To RWDLearn how integrating participant trial data and real-world data into a standard EDC system can promote success in obtaining IRB approval.
-
![GettyImages-1081869356 data]( "Accelerating Innovation In Clinical Trials With Real-World Data")
Accelerating Innovation In Clinical Trials With Real-World DataLearn about the challenge to access and connect to real-world data (RWD) – including EHR, claims, lab, and other data types once patient data is de-identified for trial purposes.
-
![GettyImages-1332353096 data]( "Readying Your Clinical Trial For Linkage With Real-World Data")
Readying Your Clinical Trial For Linkage With Real-World DataDiscover why the near ubiquity of real-world data (RWD) sources has prompted sponsors to consider RWD’s role in study programs and regulatory bodies to issue guidance on their use in clinical development.
-
![GettyImages-1869998960 patient, doctor, clincial trial]( "Understanding Phase 4 Trials: A Critical Component Of Post-Marketing Insight")
Understanding Phase 4 Trials: A Critical Component Of Post-Marketing InsightUncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.
